Market Overview

Sanofi Buys OTC Antacid Rolaids from J&J's McNeil-PPC

Related SNY
Dan Loeb's Activist Campaign Against Nestle Goes Against Decades Of History
Regeneron (REGN) Stock on Fire: What's Behind the Surge?
Good Companies From Warren Buffett's Portfolio (GuruFocus)
Related JNJ
Attention To Details: Neos' ADHD Portfolio
A New ETF For Low Vol ETFs

Sanofi (NYSE : SNY) today announced that its US Consumer Healthcare Division, Chattem, Inc., completed the acquisition of the worldwide rights to the Rolaids^® brand from McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.

Posted-In: News M&A


Related Articles (JNJ + SNY)

View Comments and Join the Discussion!